15/02/23 General Lean Life Science and Cancer Research Horizons – Applications for Oncology Development Pr...
15/02/23 General Coulter Partners places two industry-leading infectious disease experts as Board Directors at R...
30/01/23 General Grey Wolf Therapeutics Closes Oversubscribed $49 Million Series B Financing to Advance First-of...
25/01/23 General Planning permission granted for the latest phase of development at Oxford Technology Park